NCT04214704View on ClinicalTrials.gov

Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 4, 2020

Primary Completion Date

July 15, 2021

Study Completion Date

July 15, 2021

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

Genteel lancing device

Painless lancing device that helps to improve and assess self-monitoring frequency and HbA1c respectively

DEVICE

Conventional lancing device

Conventional lancing device

Trial Locations (1)

695032

Jothydev's Diabetes Research Center, Trivandrum

All Listed Sponsors
lead

Jothydev's Diabetes and Research Centre

OTHER

NCT04214704 - Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients | Biotech Hunter | Biotech Hunter